INVO Fertility (IVF) Net Cash Flow Growth (1y) (2012 - 2026)
INVO Fertility (IVF) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 76.43% |
| 10 | INVO Fertility | 1.66 Mn | -3.24 Mn | 732,978.00 | 2,754.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,754.85% |
| Sep 30, 2025 | 66.81% |
| Jun 30, 2025 | -170.13% |
| Mar 31, 2025 | -59.20% |
| Dec 31, 2024 | 132.78% |
| Sep 30, 2024 | -149.98% |
| Jun 30, 2024 | 122.54% |
| Mar 31, 2024 | -88.43% |
| Dec 31, 2023 | -320.90% |
| Sep 30, 2023 | 156.25% |
| Jun 30, 2023 | -10.55% |
| Mar 31, 2023 | 213.72% |
| Dec 31, 2022 | -120.12% |
| Sep 30, 2022 | 13.13% |
| Jun 30, 2022 | -5.48% |
| Mar 31, 2022 | -10.18% |
| Dec 31, 2021 | -89.43% |
| Sep 30, 2021 | -224.00% |
| Jun 30, 2021 | -254.27% |
| Mar 31, 2021 | -88.45% |